| 764438 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
343 Multiomic biomarker signatures identify subsets of patients who may benefit from either nivolumab or sotigalimab in combination with chemotherapy in metastatic pancreatic cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.343 |
Maurer Deena, Yu Jia Xin, Sklodowski Kamil, Tognetti Marco, Reiter Lukas, Bruderer Roland, Vowinckel Jakob, Pfeiffer Shannon, O’Hara Mark, O’Reilly Eileen, Wolff Robert, Wainberg Zev, Ko Andrew, Rahm Osama, Fisher George, Lyman Jaclyn, Cabanski Christopher, Gherardini Pier Federico, O’Donnell-Tormey Jill, LaVallee Theresa, Vonderheide Robert, Kitch Lacey |
| 764437 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
457 KEYNOTE-495/KeyImPaCT: interim analysis of a randomized, biomarker-directed, phase 2 trial of pembrolizumab-based combination therapy for non–small cell lung cancer (NSCLC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.457 |
Gutierrez Martin, Lam Wei-Sen, Hellmann Matthew, Gubens Matthew, Aggarwal Charu, Weng Tan Daniel Shao, Felip Enriqueta, Chiu Joanne WY, Lee Jong-Seok, Yang James Chih-Hsin, Garon Edward, Finocchiaro Giovanna, Ahn Myung-Ju, Luft Alexander, Landers Gregory, Basso Andrea, Ma Hua, Kobie Julie, Palcza John, Cristescu Razvan, Fong Lawrence, Snyder Alexandra, Yuan Jianda, Herbst Roy |
| 764436 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
15 First-line platinum-based chemotherapy combined with PD-1/PD-L1 inhibitors (ICI) prevents hyperprogression in non-small cell lung cancer (NSCLC) patients by reducing circulating immature neutrophils |
2021-11-01 |
10.1136/jitc-2021-sitc2021.015 |
Ferrara Roberto, Russo Giuseppe Lo, Jachetti Elena, Calareso Giuseppina, Proto Claudia, Prelaj Arsela, Galli Giulia, Signorelli Diego, Brambilla Marta, Toma Alessandro De, Occhipinti Mario, Manglaviti Sara, Apollonio Giulia, Mazzeo Laura, Ganzinelli Monica, Martinetti Antonia, Braud Filippo De, Garassino Marina, Colombo Mario Paolo, Sangaletti Sabina |
| 764435 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial |
2021-11-01 |
10.1136/jitc-2021-sitc2021.277 |
Tselikas Lambros, Robert Caroline, Dalle Stephane, Meyer Nicolas, Lebbe Celeste, Ammari Samy, Danlos François-Xavier, Roy Severine, Jannin Camille, Farhane Siham, Mourad Severine, Escriou Guillaume, Raoult Thibault, Scoazec Jean-Yves, Texier Matthieuu, Chaput-Gras Nathalie, Zitvogel Laurence, Baere Thierry De, Marabelle Aurélien |
| 764434 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
610 Sustainable regression of disseminated solid tumors mediated by in situ combinational treatment with adoptive T cell therapy and oncolytic adenovirus Delta-24-RGDOX |
2021-11-01 |
10.1136/jitc-2021-sitc2021.610 |
Jiang Hong, Shin Dong Ho, Sohoni Sagar, Nguyen Teresa, Yi Yanhua, Fan Xuejun, Gumin Joy, Singh Sanjay, Lang Frederick, Gomez-Manzano Candelaria, Fueyo Juan |
| 764433 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
99 T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants |
2021-11-01 |
10.1136/jitc-2021-sitc2021.099 |
Hirschhorn Daniel, Budhu Sadna, Schröder David, kraehenbuehl Lukas, Flammar Anne-Laurent, Chow Andrew, Schulze Isabell, Schad Sara, Ricca Jacob, Gasmi Billel, Henau Olivier De, Mangarin Levi, Redmond David, Cortez Czrina, Liu Cailian, Holland Aliya, Gigoux Mathieu, Arora Asrhi, Panageas Katherine, Rizzuto Gabrielle, Albrengues Jean, Egeblad Mikala, Wolchok Jedd, Merghoub Taha |
| 764432 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
776 The anti-tumor activity of HER-2/neu ICD therapeutic cancer vaccine (AST-301, pNGVL3-hICD) in Her2-expressed gastric cancer xenograft model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.776 |
Jo Gyeong Seok, Joung Eunkyo, Shin Jung Hyu, Lee Hye Lim, Lim Jinback, Kim Yoonyi, Park Hyo-Hyun, Shin Hunwoo, Jung Hun |
| 764431 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
775 An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.775 |
Hundt Matthias, Li Michelle, Huang Hui, Obejero-Paz Carlos, Bove Peter, Hernandez Ivan, Kundu Pratima, Kooreman Nigel, Wolpe Stephen, Bui Lynne |
| 764430 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
771 Novel lipid nanoparticle vaccine platform for efficient delivery of high- and low-affinity epitopes |
2021-11-01 |
10.1136/jitc-2021-sitc2021.771 |
Björgvinsdóttir Unnur Jóna, Carstensen Laura Stentoft, Colliander Anna, Jæhger Ditte Elisabeth, Veiga Gael Clergeaud, Halldórsdóttir Hólmfríður Rósa, Jørgensen Matilde Smærup, Christensen Esben, Vangsgaard Sara, Koukos Aristeidis, Bak Martin, Kempen Paul, Andresen Thomas Lars |
| 764429 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
770 Personalized synthetic polyepitope DNA cancer vaccines encoding a novel pyroptotic adjuvant to generate effective anti-tumor T cell immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.770 |
Bergen Jeroen Van, Arakelian Tsolere, Moharana Kedar, Teunisse Bram, Zoutendijk Iris, Camps Marcel, Arens Ramon, Ossendorp Ferry, Zondag Gerben |
